162 related articles for article (PubMed ID: 25995674)
21. [Zosteriform eruption resistant to acyclovir].
Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
[No Abstract] [Full Text] [Related]
22. Tumour-to-tumour metastasis: male breast carcinoma metastasis arising in an extrapleural solitary fibrous tumour - a case report.
Scheipl S; Moinfar F; Leithner A; Sadoghi P; Jorgensen M; Rinner B; Liegl B
Diagn Pathol; 2014 Nov; 9():203. PubMed ID: 25420931
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.
Avery-Kiejda KA; Braye SG; Mathe A; Forbes JF; Scott RJ
BMC Cancer; 2014 Jan; 14():51. PubMed ID: 24479446
[TBL] [Abstract][Full Text] [Related]
24. A Red and Swollen Eyelid. Breast carcinoma metastasis to left lacrimal gland.
Rao RC; Elner VM; Demirci H
JAMA Oncol; 2015 Jul; 1(4):537-8. PubMed ID: 26181264
[No Abstract] [Full Text] [Related]
25. Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.
Hines SL; Vallow LA; Tan WW; McNeil RB; Perez EA; Jain A
Ann Oncol; 2008 Sep; 19(9):1561-5. PubMed ID: 18534964
[TBL] [Abstract][Full Text] [Related]
26. Local therapy for triple-negative breast cancer: a comprehensive review.
Grubb W; Young R; Efird J; Jindal C; Biswas T
Future Oncol; 2017 Aug; 13(19):1721-1730. PubMed ID: 28776394
[TBL] [Abstract][Full Text] [Related]
27. Multiple cutaneous metastases from male breast carcinoma.
Karakuzu A; Koc M; Ozdemir S
J Am Acad Dermatol; 2006 Dec; 55(6):1101-2. PubMed ID: 17097408
[TBL] [Abstract][Full Text] [Related]
28. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
Iguchi C; Nio Y; Itakura M
J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
[TBL] [Abstract][Full Text] [Related]
31. A 55-Year-Old Woman With New Triple-Negative Breast Mass, Less Than 2 cm on Both Mammogram and Ultrasound.
Elias AD; Wang WS; Hardesty L
Oncology (Williston Park); 2016 Mar; 30(3):258-62. PubMed ID: 26984221
[No Abstract] [Full Text] [Related]
32. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
[TBL] [Abstract][Full Text] [Related]
33. Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer.
Gholam D; Chebib A; Hauteville D; Bralet MP; Jasmin C
Anticancer Drugs; 2007 Aug; 18(7):835-7. PubMed ID: 17581308
[TBL] [Abstract][Full Text] [Related]
34. Past, present, and future challenges in breast cancer treatment.
Sledge GW; Mamounas EP; Hortobagyi GN; Burstein HJ; Goodwin PJ; Wolff AC
J Clin Oncol; 2014 Jul; 32(19):1979-86. PubMed ID: 24888802
[No Abstract] [Full Text] [Related]
35. ["Triple negative" breast cancer].
Freres P; Collignon J; Gennigens C; Scagnol I; Rorive A; Barbeaux A; Coucke PA; Jérusalem G
Rev Med Liege; 2010 Mar; 65(3):120-6. PubMed ID: 20411815
[TBL] [Abstract][Full Text] [Related]
36. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
Kuo SH; Chen CL; Huang CS; Cheng AL
Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
[TBL] [Abstract][Full Text] [Related]
37. Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes.
Bose S
Adv Anat Pathol; 2015 Sep; 22(5):306-13. PubMed ID: 26262513
[TBL] [Abstract][Full Text] [Related]
38. Rare morphological appearance of breast carcinoma.
Elghobashy M; Shaaban AM
J Clin Pathol; 2019 Jan; 72(1):90. PubMed ID: 30131326
[No Abstract] [Full Text] [Related]
39. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G
Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592
[TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
